A detailed history of Balyasny Asset Management LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 991,704 shares of LAB stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
991,704
Previous 998,162 0.65%
Holding current value
$1.81 Million
Previous $1.77 Million 8.32%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.42 - $2.35 $9,170 - $15,176
-6,458 Reduced 0.65%
991,704 $1.91 Million
Q2 2024

Aug 14, 2024

SELL
$1.65 - $2.92 $6.35 Million - $11.2 Million
-3,846,889 Reduced 79.4%
998,162 $1.77 Million
Q1 2024

May 13, 2024

BUY
$1.87 - $2.78 $4.98 Million - $7.4 Million
2,662,864 Added 122.03%
4,845,051 $13.1 Million
Q4 2023

Feb 14, 2024

SELL
$1.59 - $2.73 $818,091 - $1.4 Million
-514,523 Reduced 19.08%
2,182,187 $4.82 Million
Q3 2023

Nov 14, 2023

BUY
$1.9 - $3.05 $1.13 Million - $1.81 Million
595,020 Added 28.31%
2,696,710 $7.82 Million
Q2 2023

Aug 14, 2023

BUY
$1.47 - $2.56 $3.09 Million - $5.38 Million
2,101,690 New
2,101,690 $4.06 Million
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.99 $1.82 Million - $4.54 Million
1,137,361 New
1,137,361 $1.82 Million
Q1 2022

May 16, 2022

SELL
$2.8 - $3.96 $1.96 Million - $2.77 Million
-700,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.63 - $6.13 $1.38 Million - $2.34 Million
381,009 Added 119.44%
700,000 $2.74 Million
Q3 2021

Nov 15, 2021

BUY
$5.5 - $7.41 $1.75 Million - $2.36 Million
318,991 New
318,991 $2.1 Million
Q2 2018

Aug 14, 2018

SELL
$4.86 - $6.24 $123,871 - $159,045
-25,488 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$5.75 - $7.97 $82,731 - $114,672
14,388 Added 129.62%
25,488 $149,000
Q4 2017

Feb 14, 2018

BUY
$4.46 - $6.45 $49,506 - $71,595
11,100
11,100 $65,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.